BioReliance Competitors and Similar CompaniesClear all

BioReliance's competitors and similar companies include ICON, Eurofins, Charles River Laboratories and Lonza.

	BioReliance BioReliance is a company that provides biopharmaceutical testing solutions.	ICON ICON is a clinical research organization that provides consulting, outsourced development, and commercialization services.	Eurofins Eurofins Scientific is a life sciences company providing laboratory services.	Charles River Laboratories Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions.	Lonza Lonza Group is a company specializing in life sciences and biotechnology solutions
Founding Date	Founding Date 1947	Founding Date 1990	Founding Date 1987	Founding Date 1947	Founding Date 1897
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Manufacturing & Industrial biotech life sciences pharma	Tags Healthcare biotech clinical research medical imaging outsourcing	Tags Healthcare biotech clinical research compliance life sciences	Tags Healthcare clinical research healthcare staffing medical diagnostics	Tags Healthcare biotech chemicals life sciences pharma
Locations	Locations Rockville, US HQ Mumbai, IN Shinagawa City, JP Glasgow, GB Stirling, GB	Locations Dublin, IE HQ Villa Adelina, AR Sydney, AU Vienna, AT Minsk, BY Minsk, BY Mechelen, BE see more	Locations Luxembourg, LU HQ Girraween, AU Leoben, AT Villach, AT Zinj, BH Baipayl, BD Brussels, BE see more	Locations Wilmington, US HQ Melbourne, AU Beerse, BE Brussels, BE São Paulo, BR Laval, CA Saint Constant, CA see more	Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more
Employees	Employees 5141% decrease	Employees 41,250	Employees 65,0004% increase	Employees 18,3002% decrease	Employees 19,7712% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 19.2 b	Valuation ($) 9.5 b	Valuation ($) 9.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $8.3b (FY, 2024)	Revenue (est.) €7.3b (FY, 2025)	Revenue (est.) $4b (FY, 2025)	Revenue (est.) CHF6.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €2.3b (FY, 2025)	Cost of goods N/A	Cost of goods CHF2.1b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $8.3b (FY, 2024)	Gross profit €5b (FY, 2025)	Gross profit N/A	Gross profit CHF4.5b (FY, 2025)
Net income	Net income N/A	Net income $791.5m (FY, 2024)	Net income €473m (FY, 2025)	Net income ($142.2m) (FY, 2025)	Net income CHF909m (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries 53 (FY, 2021)	Countries 62 (FY, 2023)	Countries 20 (FY, 2021)	Countries 28 (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 30m	Total funding raised $ 34m	Total funding raised N/A